AGEN
Price
$6.94
Change
-$0.12 (-1.70%)
Updated
Jul 14, 03:52 PM (EDT)
Capitalization
193.56M
INO
Price
$1.35
Change
-$0.00 (-0.00%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
69.31M
Interact to see
Advertisement

AGEN vs INO

Header iconAGEN vs INO Comparison
Open Charts AGEN vs INOBanner chart's image
Agenus
Price$6.94
Change-$0.12 (-1.70%)
Volume$1.38K
Capitalization193.56M
Inovio Pharmaceuticals
Price$1.35
Change-$0.00 (-0.00%)
Volume$22.33K
Capitalization69.31M
AGEN vs INO Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. INO commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and INO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (AGEN: $7.06 vs. INO: $1.36)
Brand notoriety: AGEN: Not notable vs. INO: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 483% vs. INO: 110%
Market capitalization -- AGEN: $193.56M vs. INO: $69.31M
AGEN [@Biotechnology] is valued at $193.56M. INO’s [@Biotechnology] market capitalization is $69.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGEN and INO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 5 TA indicator(s) are bullish while INO’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 5 bullish, 4 bearish.
  • INO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than INO.

Price Growth

AGEN (@Biotechnology) experienced а +16.31% price change this week, while INO (@Biotechnology) price change was +2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.18%. For the same industry, the average monthly price growth was +23.65%, and the average quarterly price growth was +32.82%.

Reported Earning Dates

AGEN is expected to report earnings on May 12, 2025.

INO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+13.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($194M) has a higher market cap than INO($69.3M). AGEN YTD gains are higher at: 157.664 vs. INO (-23.596). AGEN has higher annual earnings (EBITDA): -81.06M vs. INO (-93.37M). INO has more cash in the bank: 68.4M vs. AGEN (18.5M). INO has less debt than AGEN: INO (11.3M) vs AGEN (92M). AGEN has higher revenues than INO: AGEN (99.5M) vs INO (283K).
AGENINOAGEN / INO
Capitalization194M69.3M280%
EBITDA-81.06M-93.37M87%
Gain YTD157.664-23.596-668%
P/E Ratio0.24N/A-
Revenue99.5M283K35,159%
Total Cash18.5M68.4M27%
Total Debt92M11.3M814%
FUNDAMENTALS RATINGS
AGEN vs INO: Fundamental Ratings
AGEN
INO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3494
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (50) in the Medical Specialties industry is somewhat better than the same rating for AGEN (96) in the Biotechnology industry. This means that INO’s stock grew somewhat faster than AGEN’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AGEN (100) in the Biotechnology industry. This means that INO’s stock grew similarly to AGEN’s over the last 12 months.

INO's SMR Rating (99) in the Medical Specialties industry is in the same range as AGEN (100) in the Biotechnology industry. This means that INO’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for INO (94) in the Medical Specialties industry. This means that AGEN’s stock grew somewhat faster than INO’s over the last 12 months.

AGEN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as INO (100) in the Medical Specialties industry. This means that AGEN’s stock grew similarly to INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENINO
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRRE7.80N/A
N/A
Blue Ridge Real Estate Co.
CZASF0.01N/A
N/A
China Zhengtong Auto Services Holdings Ltd.
FXLG35.45N/A
N/A
F.S. Bancorp
CYFWF2.64N/A
N/A
Cyfrowy Polsat S.A.
CPAMF1.74-0.18
-9.37%
CAPITALAND INTEGRATED COML TR MGMT LTD

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with AXON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
-2.16%
AXON - INO
53%
Loosely correlated
-0.46%
ARRY - INO
52%
Loosely correlated
-2.23%
RPTX - INO
51%
Loosely correlated
-3.85%
ONCO - INO
50%
Loosely correlated
-3.20%
BCYC - INO
48%
Loosely correlated
-1.11%
More